Physician profile
Dennis M Smith
NPI 1386655074
$1,330.66
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $24.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $166.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.92 | 2019 | |
| Mylan Specialty L.P. | $129.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $126.96 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $92.81 | 2019-2020 | |
| Grifols USA, LLC | $91.13 | 2019 | |
| Genentech USA, INC. | $69.71 | 2019 | |
| Genzyme Corporation | $68.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.96 | 2019 | |
| Mallinckrodt Enterprises LLC | $55.35 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $44.15 | 2019 | |
| Electromed, INC. | $39.32 | 2019 | |
| Shire North American Group INC | $37.06 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.54 | 2019 | |
| Circassia INC. | $30.75 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $25.58 | 2019 | |
| Merck Sharp & Dohme LLC | $22.43 | 2019 | |
| Philips North America LLC | $18.92 | 2019 | |
| Insmed, INC. | $17.61 | 2019 | |
| Resmed Corp | $16.82 | 2019 | |
| Pfizer INC. | $14.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.